WCN26-3983 PREVALENCE AND OUTCOMES OF CEREBROVASCULAR DISEASE IN END-STAGE RENAL DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS: A CROSS-SECTIONAL STUDY

Read full text Summarise with VIRAT
Authors: NORIDJA YUSOP, Catherine Rose Ti
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cerebrovascular disease remains one of the leading causes of morbidity and mortality in End-stage renal disease patients undergoing hemodialysis. Hemodialysis patients often present with multiple comorbidities including hypertension, diabetes, coronary/peripheral artery disease, malignancy, atrial fibrillation, dyslipidemia, bleeding dyscrasias, and even a history of COVID-19 infection – each of which is independently associated with an elevated risk of cerebrovascular event. Understanding the magnitude of this problem and the underlying mechanisms is crucial for developing targeted preventive strategies and improving patient outcomes.

Fields of Study & Subjects

Dialysis and Renal Disease Management Central Venous Catheters and Hemodialysis Acute Ischemic Stroke Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105738–105738
Publication date
25 March 2026
Language
EN